The Reason I Keep Buying Amazon That Wall Street Keeps Missing

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • AWS entered Q1 2026 with a $364 billion commercial backlog, grew 28% year-over-year, and helped push consolidated operating margin to a record 13.1%.

  • AMZN trades at a trailing P/E of 29 against 77% net income growth, while both OpenAI and Anthropic now pay to run on its Trainium silicon.

  • This lithium producer surpassed a $1B private valuation, joining some of America's most powerful startups. Now you can invest in EnergyX alongside global giants like General Motors, but only through July 16. (sponsor)

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The Reason I Keep Buying Amazon That Wall Street Keeps Missing

© Sean Gallup / Staff / Getty Images Europe

I keep clicking buy on Amazon (NASDAQ:AMZN | AMZN Price Prediction), and I am not embarrassed to admit it. Every time the stock dips into the low $240s, I add. My cost basis keeps rising, my share count keeps rising, and my conviction gets louder with every filing.

Here is what pulls me back. Amazon is running the largest infrastructure buildout of my investing lifetime, and it already has the receipts to pay for it. The market keeps arguing about whether hyperscaler capex is discipline or waste. I look at the pre-committed contracts sitting behind the spend and see something Wall Street keeps glossing over.

The Backlog Nobody Wants to Talk About

AWS carried a $364 billion commercial backlog into Q1 2026, and that figure does not include the recent Anthropic deal announced for over $100 billion. Andy Jassy told analysts “there is reasonable breadth in that as well, it is not just one customer or two customers.” Against that pipeline, AWS grew 28% year over year to $37.59 billion, the fastest pace in 15 quarters, at a 37.7% operating margin.

Then the silicon. Amazon’s chips business is running at a $20 billion annual revenue run rate, growing triple digits year over year. Trainium alone carries over $225 billion in revenue commitments. Jassy said “at scale, we expect Trainium will save us tens of billions of dollars of CapEx each year and provide several hundred basis points of operating margin advantage”. That is the math I keep chewing on. Amazon owns the chip stack for the AI workloads it can move in-house.

Third, the boring engine keeps compounding. Advertising crossed $70 billion in TTM revenue while growing 24%, and unit growth in Stores hit 15%, the highest since the tail end of covid lockdowns. Consolidated operating margin came in at 13.1%, the highest ever.

Why Not Microsoft or Alphabet

The question I get asked most: why not Microsoft (NASDAQ:MSFT) or Alphabet (NASDAQ:GOOGL)? I own the neighborhood. Amazon is where I keep adding. Microsoft leans on OpenAI’s roadmap for its differentiated AI story, and Google Cloud remains the third player in enterprise share. Amazon just booked OpenAI itself for approximately 2 GW of Trainium capacity beginning in 2027 and Anthropic for up to 5 GW. The two leading AI labs are now paying to run on Amazon silicon. At a trailing P/E of 29 against 76.65% year-over-year net income growth, I am paying below-market multiples for the fastest hyperscaler in the group.

The Real Risk

The real risk is cash. Free cash flow TTM collapsed 95% to $1.2 billion as capex hit $44.2 billion in a single quarter, and long-term debt climbed to $119.1 billion from $65.6 billion year over year. The spend would scare me if it were speculative. Instead, Jassy said Amazon has “customer commitments for a substantial portion” of that 2026 spend, and the monetization window on new capacity runs 6 to 24 months against assets with 30+ year useful lives on data centers. The math works if you let it play out.

I keep buying because the backlog is signed, the silicon is shipping, the consolidated margin line just hit an all-time high, and the stock trades at $247.49 against an analyst consensus target of $312.91 with 62 buy ratings and zero sells. Until the receipts stop arriving, my finger stays on the buy button.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

ABT Vol: 31,220,729
JBHT Vol: 2,452,011
ERIE Vol: 418,377
DXCM Vol: 6,483,511
CTAS Vol: 4,194,261

Top Losing Stocks

STX Vol: 6,147,953
GLW Vol: 17,544,717
WDC Vol: 10,484,491
CTRA Vol: 73,319,495
SMCI Vol: 35,105,280